🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
March 2026
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — March 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(1861)
All (1861)
Buys (167)
Sells (1694)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 12, 2026
Sale
Shares
600
Price
$542.33
Total Value
$325.40K
Shares Held After
650
% of Holdings
48.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 12, 2026
Sale
Shares
400
Price
$541.31
Total Value
$216.52K
Shares Held After
1,250
% of Holdings
24.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 12, 2026
Sale
Shares
1,240
Price
$539.82
Total Value
$669.37K
Shares Held After
1,650
% of Holdings
42.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 12, 2026
Sale
Shares
720
Price
$538.94
Total Value
$388.04K
Shares Held After
2,890
% of Holdings
19.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 12, 2026
Sale
Shares
1,077
Price
$537.90
Total Value
$579.31K
Shares Held After
3,610
% of Holdings
23.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 12, 2026
Sale
Shares
1,772
Price
$536.83
Total Value
$951.27K
Shares Held After
4,687
% of Holdings
27.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 12, 2026
Sale
Shares
1,955
Price
$536.02
Total Value
$1.05M
Shares Held After
6,459
% of Holdings
23.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 12, 2026
Sale
Shares
60
Price
$532.97
Total Value
$31.98K
Shares Held After
8,930
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Mar 12, 2026
Sale
Shares
640
Price
$532.16
Total Value
$340.58K
Shares Held After
8,990
% of Holdings
6.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Claritev Corp
(CTEV)
Kim Michael
— EVP, Chief Digital Officer
Mar 12, 2026
Purchase
Shares
15,000
Price
$16.50
Total Value
$247.50K
Shares Held After
182,878
% of Holdings
8.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
AtriCure, Inc.
(ATRC)
Doraiswamy Vinayak
— Chief Scientific Officer
Mar 12, 2026
Sale
Shares
5,000
Price
$29.83
Total Value
$149.15K
Shares Held After
96,875
% of Holdings
4.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adaptive Biotechnologies Corp
(ADPT)
RUBINSTEIN JULIE
— President and COO
Mar 12, 2026
Sale
Shares
5,400
Price
$13.43
Total Value
$72.52K
Shares Held After
512,272
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adaptive Biotechnologies Corp
(ADPT)
RUBINSTEIN JULIE
— President and COO
Mar 12, 2026
Sale
Shares
13,660
Price
$12.63
Total Value
$172.53K
Shares Held After
517,672
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Sarepta Therapeutics, Inc.
(SRPT)
Mayo Stephen
— Director
Mar 12, 2026
Sale
Shares
7,239
Price
$17.02
Total Value
$123.21K
Shares Held After
1,765
% of Holdings
80.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dianthus Therapeutics, Inc. /DE/
(DNTH)
CARR EDWARD
— CHIEF ACCOUNTING OFFICER
Mar 12, 2026
Sale
Shares
300
Price
$85.53
Total Value
$25.66K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dianthus Therapeutics, Inc. /DE/
(DNTH)
CARR EDWARD
— CHIEF ACCOUNTING OFFICER
Mar 12, 2026
Sale
Shares
200
Price
$83.38
Total Value
$16.68K
Shares Held After
300
% of Holdings
40.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dianthus Therapeutics, Inc. /DE/
(DNTH)
CARR EDWARD
— CHIEF ACCOUNTING OFFICER
Mar 12, 2026
Sale
Shares
3,865
Price
$82.66
Total Value
$319.48K
Shares Held After
500
% of Holdings
88.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dianthus Therapeutics, Inc. /DE/
(DNTH)
Garcia Marino
— Director
Mar 12, 2026
Sale
Shares
900
Price
$85.53
Total Value
$76.98K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dianthus Therapeutics, Inc. /DE/
(DNTH)
CARR EDWARD
— CHIEF ACCOUNTING OFFICER
Mar 12, 2026
Sale
Shares
23,465
Price
$81.75
Total Value
$1.92M
Shares Held After
4,365
% of Holdings
84.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dianthus Therapeutics, Inc. /DE/
(DNTH)
Garcia Marino
— Director
Mar 12, 2026
Sale
Shares
200
Price
$83.38
Total Value
$16.68K
Shares Held After
900
% of Holdings
18.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dianthus Therapeutics, Inc. /DE/
(DNTH)
CARR EDWARD
— CHIEF ACCOUNTING OFFICER
Mar 12, 2026
Sale
Shares
15,852
Price
$80.71
Total Value
$1.28M
Shares Held After
27,830
% of Holdings
36.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dianthus Therapeutics, Inc. /DE/
(DNTH)
Garcia Marino
— Director
Mar 12, 2026
Sale
Shares
12,796
Price
$82.60
Total Value
$1.06M
Shares Held After
1,100
% of Holdings
92.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dianthus Therapeutics, Inc. /DE/
(DNTH)
Garcia Marino
— Director
Mar 12, 2026
Sale
Shares
65,517
Price
$81.74
Total Value
$5.36M
Shares Held After
13,896
% of Holdings
82.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dianthus Therapeutics, Inc. /DE/
(DNTH)
Garcia Marino
— Director
Mar 12, 2026
Sale
Shares
43,505
Price
$80.69
Total Value
$3.51M
Shares Held After
79,413
% of Holdings
35.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Dianthus Therapeutics, Inc. /DE/
(DNTH)
Randhawa Simrat
— EVP, Head of R&D
Mar 12, 2026
Sale
Shares
33,830
Price
$81.48
Total Value
$2.76M
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
STAAR SURGICAL CO
(STAA)
BROADWOOD PARTNERS, L.P.
— Director
Mar 12, 2026
Purchase
Shares
299,432
Price
$18.12
Total Value
$5.42M
Shares Held After
15,807,825
% of Holdings
1.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alignment Healthcare, Inc.
(ALHC)
Maroney Dawn Christine
— President
Mar 12, 2026
Sale
Shares
1,763
Price
$16.99
Total Value
$29.96K
Shares Held After
963,702
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alignment Healthcare, Inc.
(ALHC)
Maroney Dawn Christine
— President
Mar 12, 2026
Sale
Shares
27,350
Price
$17.48
Total Value
$477.97K
Shares Held After
965,465
% of Holdings
2.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alignment Healthcare, Inc.
(ALHC)
KAO JOHN E
— Director
Mar 12, 2026
Sale
Shares
2,961
Price
$16.99
Total Value
$50.31K
Shares Held After
1,519,480
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alignment Healthcare, Inc.
(ALHC)
Scavo Robert L.
— Chief Information Officer
Mar 12, 2026
Sale
Shares
245
Price
$16.99
Total Value
$4.16K
Shares Held After
498,970
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alignment Healthcare, Inc.
(ALHC)
KAO JOHN E
— Director
Mar 12, 2026
Sale
Shares
45,938
Price
$17.48
Total Value
$802.81K
Shares Held After
1,522,441
% of Holdings
2.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alignment Healthcare, Inc.
(ALHC)
Scavo Robert L.
— Chief Information Officer
Mar 12, 2026
Sale
Shares
3,799
Price
$17.48
Total Value
$66.39K
Shares Held After
499,215
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Crinetics Pharmaceuticals, Inc.
(CRNX)
Vivaldi Coelho Rogerio
— Director
Mar 12, 2026
Sale
Shares
523
Price
$36.77
Total Value
$19.23K
Shares Held After
16,300
% of Holdings
3.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Crinetics Pharmaceuticals, Inc.
(CRNX)
Vivaldi Coelho Rogerio
— Director
Mar 12, 2026
Sale
Shares
4,477
Price
$36.08
Total Value
$161.53K
Shares Held After
16,823
% of Holdings
21.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SI-BONE, Inc.
(SIBN)
Nishimura Mika
— Director
Mar 12, 2026
Sale
Shares
4,100
Price
$13.83
Total Value
$56.70K
Shares Held After
32,716
% of Holdings
11.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
PTC THERAPEUTICS, INC.
(PTCT)
Klein Matthew B.
— Director
Mar 12, 2026
Sale
Shares
2,662
Price
$64.08
Total Value
$170.58K
Shares Held After
396,920
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MOLINA HEALTHCARE, INC.
(MOH)
ROMNEY RONNA
— Director
Mar 12, 2026
Sale
Shares
506
Price
$146.92
Total Value
$74.34K
Shares Held After
17,227
% of Holdings
2.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
enVVeno Medical Corp
(NVNO)
Duhay Francis
— Director
Mar 12, 2026
Sale
Shares
140
Price
$11.52
Total Value
$1.61K
Shares Held After
2,502
% of Holdings
5.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CASTLE BIOSCIENCES INC
(CSTL)
MAETZOLD DEREK J
— Director
Mar 12, 2026
Sale
Shares
23,179
Price
$25.28
Total Value
$585.94K
Shares Held After
71,558
% of Holdings
24.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BiomX Inc.
(PHGE)
Yeganeh Reuven
— Director
Mar 12, 2026
Sale
Shares
300,000
Price
$5.00
Total Value
$1.50M
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CHEMED CORP
(CHE)
MCNAMARA KEVIN J
— Director
Mar 12, 2026
Sale
Shares
2,000
Price
$403.18
Total Value
$806.36K
Shares Held After
93,719
% of Holdings
2.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ONCOLYTICS BIOTECH INC
(ONCY)
Kelly Jared
— Director
Mar 12, 2026
Purchase
Shares
5,050
Price
$0.96
Total Value
$4.85K
Shares Held After
114,050
% of Holdings
4.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
AdaptHealth Corp.
(AHCO)
CASHIN RICHARD M JR
— 10% Owner
Mar 12, 2026
Purchase
Shares
689,336
Price
$9.73
Total Value
$6.71M
Shares Held After
15,864,871
% of Holdings
4.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Lineage Cell Therapeutics, Inc.
(LCTX)
Culley Brian M
— Director
Mar 12, 2026
Purchase
Shares
15,000
Price
$1.62
Total Value
$24.38K
Shares Held After
255,516
% of Holdings
5.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MYOMO, INC.
(MYO)
Getz Heather C
— Director
Mar 12, 2026
Purchase
Shares
70,000
Price
$0.73
Total Value
$50.96K
Shares Held After
111,754
% of Holdings
62.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adaptive Biotechnologies Corp
(ADPT)
RUBINSTEIN JULIE
— President and COO
Mar 11, 2026
Sale
Shares
19,060
Price
$14.08
Total Value
$268.36K
Shares Held After
516,610
% of Holdings
3.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adaptive Biotechnologies Corp
(ADPT)
RUBINSTEIN JULIE
— President and COO
Mar 11, 2026
Sale
Shares
122,523
Price
$13.17
Total Value
$1.61M
Shares Held After
520,948
% of Holdings
19.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adaptive Biotechnologies Corp
(ADPT)
LO FRANCIS
— Chief People Officer
Mar 11, 2026
Sale
Shares
30,593
Price
$14.08
Total Value
$430.75K
Shares Held After
291,374
% of Holdings
9.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adaptive Biotechnologies Corp
(ADPT)
GRIFFIN MICHELLE RENEE
— Director
Mar 11, 2026
Sale
Shares
15,394
Price
$13.91
Total Value
$214.13K
Shares Held After
15,625
% of Holdings
49.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Adaptive Biotechnologies Corp
(ADPT)
ROBINS CHAD M
— Director
Mar 11, 2026
Sale
Shares
329,600
Price
$13.17
Total Value
$4.34M
Shares Held After
2,301,113
% of Holdings
12.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 501–550 of 1861 transactions (page 11 of 38)
Version: v26.3.29